Botulinum toxin in the treatment of OAB, BPH, and IC

Toxicon

Volumn 54, Issue 5, 2009, Pages 639-646

  Smith, Christopher P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Neurogenic detrusor overactivity

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; PLACEBO; RESINIFERATOXIN;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLADDER CAPACITY; BLADDER DYSFUNCTION; CATHETERIZATION; CLINICAL FEATURE; CLINICAL TRIAL; CYSTALGIA; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; HUMAN; IDIOPATHIC DETRUSOR OVERACTIVITY; INJECTION; INTERSTITIAL CYSTITIS; NOCTURIA; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SIDE EFFECT; SPINAL CORD INJURY; URGE INCONTINENCE; URINARY FREQUENCY; URINARY URGENCY; URINE FLOW RATE;

BOTULINUM TOXIN TYPE A; CYSTITIS, INTERSTITIAL; HUMANS; MALE; MUSCLE HYPERTONIA; NEUROMUSCULAR AGENTS; PROSTATIC HYPERPLASIA; URINARY BLADDER, OVERACTIVE;

EID: 68849127390     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.02.021     Document Type: Article

References (40)

1. Altaweel W., Jednack R., Bilodeau C., and Corcos J. Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J. Urol 175 3 Pt 1 (2006) 1102-1105
2. Brubaker L., Richter H.E., Visco A., Mahajan S., Nygaard I., Braun T.M., Barber M.D., Menefee S., Schaffer J., Weber A.M., and Wei J. Pelvic Floor Disorders Network Refractory idiopathic urge urinary incontinence and botulinum A injection. J. Urol 180 1 (2008) 217-222
3. Chuang Y.-C., Chiang P.-H., Huang C.-C., et al. Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology 66 (2005) 775-779
4. Chuang Y.-C., Chiang P.-H., Yoshimura N., et al. Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia. BJU Int 98 (2006) 1033-1037
5. Comperat E., Reitz A., Delcourt A., Capron F., Denys P., and Chartier-Kastler E. Histologic features in the urinary bladder wall affected from neurogenic overactivity - a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur. Urol 50 5 (2006) 1058-1064
6. Del Popolo G., Filocamo M.T., Li Marzi V., Macchiarella A., Cecconi F., Lombardi G., Nicita G.,. Neurogenic detrusor overactivity treated with English botulinum toxin a: 8-year experience of one single centre. Eur. Urol 53 5 (2008) 1013-1019
7. Flynn M.K., Webster G.D., Amundsen C.,. The effect of botulinum-A toxin on patients with severe urge urinary incontinence. J. Urol 172 6 Pt 1 (2004) 2316-2320
8. Ghei M., Maraj B.H., Miller R., Nathan S., O'Sullivan C., Fowler C.J., Shah P.J., Malone-Lee J.,. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial. J. Urol 174 5 (2005) 1873-1877
9. Giannantoni A., Di Stasi S.M., Stephen R.L., Bini V., Costantini E., Porena M.,. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J. Urol 172 1 (2004) 240-243
10. Giannantoni A., Porena M., Costantini E., Zucchi A., Mearini L., Mearini E.,. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year follow-up. J. Urol 179 3 (2008) 1031-1034
11. Grosse J., Kramer G., Stohrer M.,. Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur. Urol 47 5 (2005) 653-659
12. Haferkamp A., Schurch B., Reitz A., Krengel U., Grosse J., Kramer G., Schumacher S., Bastian P.J., Buttner R., Muller S.C., Stohrer M.,. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Eur. Urol 46 6 (2004) 784-791
13. Hernandez R.D., Hurwitz R.S., Foote J.E., et al. Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J. Urol 152 5 Pt 1 (1994) 1582
14. Karsenty G., Denys P., Amarenco G., De Seze M., Gamé X., Haab F., Kerdraon J., Perrouin-Verbe B., Ruffion A., Saussine C., Soler J.M., Schurch B., Chartier-Kastler E.,. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur. Urol 53 2 (2008) 275-287
15. Kessler T.M., Danuser H., Schumacher M., Studer U.E., and Burkhard F.C. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?. Neurourol. Urodyn 24 3 (2005) 231-236
16. Klaphajone J., Kitisomprayoonkul W., and Sriplakit S. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions. Arch. Phys. Med. Rehabil 86 11 (2005) 2114-2118
17. Kuo H.C. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 63 5 (2004) 868-872
18. Kuo H.-C. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics. Urology 66 1 (2005) 94-98
19. Kuo H.-C. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis. Urol. Int 75 2 (2005) 170-174
20. Kuo H.-C. Prostatic botulinum A toxin injection - an alternative treatment for benign prostatic obstruction in poor surgical candidates. Urology 65 (2005) 670-674
21. Liu H.T., and HC K. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 70 3 (2007) 463-468
22. Maria G., Brisinda G., Massimo I., et al. Relief of botulinum toxin if voiding dysfunction due to benign prostatic hyperplasia: results of randomized, placebo-controlled study. Urology 62 (2003) 259-265
23. Meunier F.A., Schiavo G., Molgo J.,. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J. Physiol. Paris 96 1-2 (2002) 105-113
24. Park D.S., Cho T.W., Lee Y.K., et al. Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia. Yonsei Med. J 47 5 (2006) 706-714
25. Popat R., Apostolidis A., Kalsi V., Gonzales G., Fowler C.J., Dasgupta P.,. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J. Urol 174 3 (2005) 984-989
26. Rapp D.E., Turk K.W., Bales G.T., Cook S.,. Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder. J. Urol 175 3 Pt 1 (2006) 1138-1142
27. Reitz A., Stohrer M., Kramer G., Del Popolo G., Chartier-Kastler E., Panneck J., et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for neurogenic incontinence. J. Urol 169 Suppl 4 (2003) 373
28. Sahai A., Khan M.S., Dasgupta P.,. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J. Urol 177 6 (2007) 2231-2236
29. Schmid D.M., Sauermann P., Werner M., Schuessler B., Blick N., Muentener M., Strebel R.T., Perucchini D., Scheiner D., Schaer G., John H., Reitz A., Hauri D., Schurch B.,. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J. Urol 176 1 (2006) 177-185
30. Schulte-Baukloh H., Michael T., Schobert J., Stolze T., and Knispel H.H. Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59 (2002) 325
31. Schulte-Baukloh H., Knispel H.H., Stolze T., Weiss C., Michael T., and Miller K. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology 66 4 (2005) 865-670discussion 870
32. Schulte-Baukloh H., Weiss C., Stolze T., Herholz J., Sturzebecher B., Miller K., and Knispel H.H. Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur. Urol 48 6 (2005) 984-990
33. Schulte-Baukloh H., Weiss C., Stolze T., Sturzebecher B., and Knispel H.H. Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 66 1 (2005) 82-87
34. Schurch B., Stohrer M., Kramer G., Schmid D.M., Gaul G., and Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J. Urol 164 (2000) 692-697
35. Schurch B., de Seze M., Denys P., Chartier-Kastler E., Haab F., Everaert K., Plante P., Perrouin-Verbe B., Kumar C., Fraczek S., and Brin M.F. Botox Detrusor Hyperreflexia Study Team Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J. Urol 174 1 (2005) 196-200
36. Silva J., Silva C., Saraiva L., Silva A., Pinto R., Dinis P., and Cruz F. Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption. Eur. Urol 53 1 (2008) 153-159
37. Skobejko-Wlodarska L., Strulak K., Nachulewicz P., et al. Bladder autoaugmentation in myelodysplastic children. Br. J. Urol 81 Suppl 3 (1998) 114
38. Smith C.P., Radziszewski P., Borkowski A., et al. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 64 5 (2004) 871-875
39. Smith C.P., Nishiguchi J., O'Leary M., Yoshimura N., and Chancellor M.B. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65 1 (2005) 37-41
40. Werner M., Schmid D.M., and Schussler B. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am. J. Obstet. Gynecol 192 5 (2005) 1735-1740